View in EDS

Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.

Saved in:
Bibliographic Details
Title: Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.
Authors: Khoo NKH; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore., Lim JME; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore., Gill US; Barts Liver Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, Mile End Road, London E1, UK., de Alwis R; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.; Viral Research and Experimental Medicine Centre (ViREMiCS), SingHealth Duke-NUS Academic Medical Centre, Singapore 169856, Singapore., Tan N; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore., Toh JZN; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.; Viral Research and Experimental Medicine Centre (ViREMiCS), SingHealth Duke-NUS Academic Medical Centre, Singapore 169856, Singapore., Abbott JE; Barts Liver Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, Mile End Road, London E1, UK., Usai C; Barts Liver Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, Mile End Road, London E1, UK., Ooi EE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.; Viral Research and Experimental Medicine Centre (ViREMiCS), SingHealth Duke-NUS Academic Medical Centre, Singapore 169856, Singapore., Low JGH; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.; Viral Research and Experimental Medicine Centre (ViREMiCS), SingHealth Duke-NUS Academic Medical Centre, Singapore 169856, Singapore.; Department of Infectious Diseases, Singapore General Hospital, Singapore 169856, Singapore., Le Bert N; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore., Kennedy PTF; Barts Liver Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, Mile End Road, London E1, UK., Bertoletti A; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.; Singapore Immunology Network, A∗STAR, Singapore 138648, Singapore.
Source: Med (New York, N.Y.) [Med] 2022 Feb 11; Vol. 3 (2), pp. 104-118.e4. Date of Electronic Publication: 2022 Jan 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med
Database: MEDLINE Ultimate
Description
ISSN:2666-6340
DOI:10.1016/j.medj.2021.12.004